


Vasgen Limited Revenue
Biotechnology Research • London, England, United Kingdom • 1-10 Employees
Vasgen Limited revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Vasgen Limited
Yatin Patel
Coo And Co-Founder
Company overview
| Headquarters | London Bioscience Innovation Centre, 2 Royal College Street, LONDON, NW1 0NH, GB |
| Phone number | +442076912149 |
| Website | |
| Keywords | Therapeutic Antibodies, Drug Discovery & Development, Cancer Therapeutics, Antibody Inhibitor Of Metalloprotease (Abimp), Ocular Therapeutics |
| Founded | 2011 |
| Employees | 1-10 |
| Socials |
About Vasgen Limited
VASGEN LIMITED is an early-stage biotech company based in London UK developing novel monoclonal antibody therapeutics for unmet clinical needs in ophthalmology and cancer medicine. The company is developing a breakthrough antibody platform (AbIMP®) that generates selective inhibitors of therapeutically important but previously intractable metzincin protease targets.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Vasgen Limited has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Vasgen Limited has never raised funding before.
Vasgen Limited Tech Stack
Discover the technologies and tools that power Vasgen Limited's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
Hosting
Programming languages
Blogs
Databases
Miscellaneous
Frequently asked questions
4.8
40,000 users



